Medicure Company Profile (CVE:MPH)

About Medicure (CVE:MPH)

Medicure logoMedicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company operates in the biopharmaceutical industry segment. The Company's primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the Company's United States subsidiary, Medicure Pharma, Inc. AGGRASTAT, a glycoprotein IIb/IIIa inhibitor (GPI), is used for the treatment of acute coronary syndrome (ACS). The Company is also engaged in the development of TARDOXAL for neurological disorders, such as Tardive Dyskinesia (TD). The Company has completed Phase IIa stage of development for TARDOXAL. The Company is also developing Transdermal AGGRASTAT, a cure for acute cardiology. Transdermal AGGRASTAT is in preclinical-stage of development.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: CVE:MPH
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: C$113.38 million
  • Outstanding Shares: 15,532,000
Average Prices:
  • 52 Week Range: C$5.20 - C$10.67
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
Sales & Book Value:
  • Annual Revenue: C$37.78 million
  • Price / Sales: 3.00
  • Book Value: C$2.37 per share
  • Price / Book: 3.08
Profitability:
  • EBIDTA: C$12.14 million
Misc:
  • Average Volume: 22,921 shs.
  • Short Ratio: 0.03
 

Frequently Asked Questions for Medicure (CVE:MPH)

What is Medicure's stock symbol?

Medicure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."

Who are some of Medicure's key competitors?

How do I buy Medicure stock?

Shares of Medicure and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How much does a share of Medicure stock cost?

One share of Medicure stock can currently be purchased for approximately C$7.30.

Analyst Ratings

Consensus Ratings for Medicure (CVE:MPH) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Medicure (CVE:MPH)
Show:
DateFirmActionRatingPrice TargetDetails
5/4/2016M PartnersReiterated RatingBuyView Rating Details
1/12/2016MackieBoost Price TargetBuyC$8.00View Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for Medicure (CVE:MPH)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Medicure (CVE:MPH)
2017 EPS Consensus Estimate: $0.96
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.09$0.09$0.09
Q2 20171$0.27$0.27$0.27
Q3 20171$0.29$0.29$0.29
Q4 20171$0.31$0.31$0.31
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Medicure (CVE:MPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Medicure (CVE:MPH)
Insider Trades by Quarter for Medicure (CVE:MPH)
Insider Trades by Quarter for Medicure (CVE:MPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/3/2017Graeme William MerchantInsiderBuy1,000C$7.07C$7,070.00
5/2/2017Albert David FriesenDirectorBuy1,100C$7.59C$8,349.00
3/17/2016Albert David FriesenDirectorBuy1,100C$5.55C$6,105.00
3/16/2016Graeme William MerchantInsiderBuy1,650C$6.40C$10,560.00
3/11/2016Graeme William MerchantInsiderBuy1,500C$6.30C$9,450.00
3/8/2016Graeme William MerchantInsiderSell6,300C$7.01C$44,163.00
9/9/2015Elliott International CapitalInsiderSell1,426,002C$2.98C$4,249,485.96
1/7/2015Albert David FriesenDirectorBuy2,900C$2.01C$5,829.00
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Medicure (CVE:MPH)
Latest Headlines for Medicure (CVE:MPH)
Source:
DateHeadline
americanbankingnews.com logoAnalysts Set Expectations for Medicure Inc's Q1 2017 Earnings (MPH)
www.americanbankingnews.com - May 25 at 7:18 AM
americanbankingnews.com logoM Partners Comments on Medicure Inc's FY2017 Earnings (MPH)
www.americanbankingnews.com - May 24 at 8:32 AM
thestreet.com logoMedicure Becomes Oversold (MPH)
www.thestreet.com - May 23 at 6:10 PM
thestreet.com logoInput Capital (INP) Shares Cross 2% Yield Mark
www.thestreet.com - May 19 at 11:16 AM
bizjournals.com logoMedicure Q1 Results and Conference Call Dates
www.bizjournals.com - May 19 at 11:16 AM
thestreet.com logoAutoCanada (ACQ) Shares Cross 2% Yield Mark
www.thestreet.com - May 16 at 6:24 PM
thestreet.com logoNotable Two Hundred Day Moving Average Cross - SII
www.thestreet.com - May 15 at 6:00 PM
thestreet.com logoOversold Conditions For Badger Daylighting (BAD)
www.thestreet.com - May 13 at 8:48 AM
thestreet.com logoCWX Crosses Above Key Moving Average Level
www.thestreet.com - May 12 at 1:51 AM
thestreet.com logoAltius Minerals Is Now Oversold (ALS)
www.thestreet.com - May 10 at 6:42 PM
thestreet.com logoOversold Conditions For Stingray Digital Group (RAY-A)
www.thestreet.com - May 9 at 6:17 PM
thestreet.com logoRSI Makes Bullish Cross Above Critical Moving Average
www.thestreet.com - May 5 at 11:58 PM
thestreet.com logoRSI Alert: Alaris Royalty (AD) Now Oversold
www.thestreet.com - May 4 at 6:41 PM
thestreet.com logoACQ.CA Makes Notable Cross Below Critical Moving Average
www.thestreet.com - May 3 at 5:40 PM
thestreet.com logoSilvercorp Metals (SVM) Shares Cross Below 200 DMA
www.thestreet.com - May 1 at 5:36 PM
americanbankingnews.com logoM Partners Weighs in on Medicure Inc's FY2017 Earnings (MPH)
www.americanbankingnews.com - May 1 at 9:20 AM
thestreet.com logoCBL.CA Dividend Yield Pushes Past 7%
www.thestreet.com - April 29 at 8:24 AM
prnewswire.com logoMedicure Reports Financial Results for Quarter and Year Ended December 31, 2016 - PR Newswire (press release)
www.prnewswire.com - April 28 at 7:39 PM
thestreet.com logoFC Crosses Above 7% Yield Territory
www.thestreet.com - April 28 at 9:11 AM
thestreet.com logoLBS Crosses Above 12% Yield Territory
www.thestreet.com - April 26 at 11:44 PM
thestreet.com logoReminder - Atrium Mortgage Investment (AI) Goes Ex-Dividend Soon
www.thestreet.com - April 25 at 5:55 AM
thestreet.com logoSupremex (SXP) Shares Cross 5% Yield Mark
www.thestreet.com - April 21 at 6:27 PM
americanbankingnews.com logoMedicure Inc Expected to Post FY2017 Earnings of $0.65 Per Share (MPH)
www.americanbankingnews.com - April 21 at 1:06 PM
thestreet.com logoMedicure Getting Very Oversold (MPH)
www.thestreet.com - April 19 at 6:40 PM
thestreet.com logoRelative Strength Alert For Gluskin Sheff (GS)
www.thestreet.com - April 17 at 5:52 PM
thestreet.com logoARE Makes Notable Cross Below Critical Moving Average
www.thestreet.com - April 13 at 6:20 PM
baystreet.ca logoResearch Reports Initiated on Healthcare Stocks Kane Biotech, Eastwood Bio-Medical Canada, iCo Therapeutics, and ... - Baystreet.ca
www.baystreet.ca - April 13 at 8:34 AM
thestreet.com logoCNL Crosses Above Key Moving Average Level
www.thestreet.com - April 13 at 12:33 AM
thestreet.com logoSJR-A Crosses Below Key Moving Average Level
www.thestreet.com - April 12 at 7:37 AM
thestreet.com logoNorth American Palladium (PDL) Shares Cross Above 200 DMA
www.thestreet.com - April 7 at 7:06 PM
finance.yahoo.com logoMedicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017 - Yahoo Finance
finance.yahoo.com - March 31 at 9:34 AM
streetinsider.com logoForm 6-K MEDICURE INC For: Mar 29
www.streetinsider.com - March 29 at 7:15 PM
streetinsider.com logoMEDICURE INC. - StreetInsider.com
www.streetinsider.com - March 24 at 6:36 PM
thestreet.com logoReminder - Morguard Real Estate Investment Trust (MRT-UN) Goes Ex-Dividend Soon
www.thestreet.com - December 12 at 6:44 PM
marketwatch.com logoMedicure Closes Acquisition of Majority Interest in Apicore - MarketWatch
www.marketwatch.com - December 2 at 6:19 PM
finance.yahoo.com logoCrown Capital Partners Completes $60.0 Million Term Loan with Medicure Inc.
finance.yahoo.com - November 18 at 9:04 AM
marketwatch.com logoMedicure Exercises Option to Acquire Majority Interest in Apicore
www.marketwatch.com - November 18 at 9:04 AM
thestreet.com logoReminder - Morguard North American Residential Real Estate Investment Trust (MRG-UN) Goes Ex-Dividend Soon
www.thestreet.com - October 26 at 6:15 PM
thestreet.com logoReminder - InterRent Real Estate Investment Trust (IIP-UN) Goes Ex-Dividend Soon
www.thestreet.com - September 27 at 10:49 AM
finance.yahoo.com logoMedicure Reports Second Quarter 2016 Financial Results
finance.yahoo.com - August 11 at 9:26 AM
finance.yahoo.com logoMedicure Inc. (MPH.V)
finance.yahoo.com - February 24 at 10:28 AM
seekingalpha.com logoUndervalued And Underfollowed; Medicure Is My Favorite Pharma Small Cap
seekingalpha.com - February 17 at 10:03 AM
thestreet.com logoMedicure To Present At Cantech Investment Conference
www.thestreet.com - January 22 at 9:43 AM

Social

Chart

Medicure (MPH) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff